Related Experiment Videos
Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester:
G Blanch1, S Quenby, E S Ballantyne
1Department of Obstetrics and Gynaecology, University of Liverpool, Liverpool L69 3BX.
BMJ (Clinical Research Ed.)
|June 20, 1998
Abstract
No abstract available in PubMed .
Keywords:
Abortifacient AgentsAbortion, Drug InducedAbortion, InducedAbortion, SpontaneousBiologyClinical ResearchCongenital AbnormalitiesDeveloped CountriesDiseasesEndocrine SystemEnglandEuropeFamily PlanningFertility Control, PostconceptionHormone AntagonistsHormonesIncidenceMeasurementMisoprostolNeonatal Diseases And AbnormalitiesNorthern EuropePhysiologyPregnancy ComplicationsProstaglandinsProstaglandins, SyntheticResearch MethodologyResearch ReportRu-486United Kingdom